Boston Trust Walden Corp Grows Stock Position in Teradyne, Inc. $TER

Key Points

• Boston Trust Walden Corp increased its stake in Teradyne, Inc. by 5.6%, now owning approximately 427,399 shares worth about $38.4 million.
• Teradyne's recent earnings report showed an EPS of $0.57, surpassing analysts' estimates, despite a 10.7% year-over-year revenue decrease.
• The company declared a quarterly dividend of $0.12 per share with an annual dividend yield of 0.4%, reflecting a payout ratio of 16.61%.

Boston Trust Walden Corp lifted its stake in Teradyne, Inc. (NASDAQ:TER - Free Report) by 5.6% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 427,399 shares of the company's stock after purchasing an additional 22,635 shares during the period. Boston Trust Walden Corp owned about 0.27% of Teradyne worth $38,432,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of TER. Berbice Capital Management LLC boosted its holdings in Teradyne by 200.0% in the first quarter. Berbice Capital Management LLC now owns 300 shares of the company's stock valued at $25,000 after purchasing an additional 200 shares during the period. Manchester Capital Management LLC boosted its holdings in Teradyne by 44.7% in the first quarter. Manchester Capital Management LLC now owns 453 shares of the company's stock valued at $37,000 after purchasing an additional 140 shares during the period. Brooklyn Investment Group boosted its holdings in Teradyne by 189.9% in the first quarter. Brooklyn Investment Group now owns 461 shares of the company's stock valued at $38,000 after purchasing an additional 302 shares during the period. Steph & Co. acquired a new stake in Teradyne in the second quarter valued at $43,000. Finally, Summit Securities Group LLC acquired a new stake in Teradyne in the first quarter valued at $58,000. 99.77% of the stock is currently owned by hedge funds and other institutional investors.

Teradyne Stock Performance

TER opened at $136.97 on Wednesday. The business's 50-day simple moving average is $122.67 and its 200-day simple moving average is $97.48. Teradyne, Inc. has a one year low of $65.77 and a one year high of $150.71. The stock has a market capitalization of $21.79 billion, a P/E ratio of 47.39, a price-to-earnings-growth ratio of 2.93 and a beta of 1.82.

Teradyne (NASDAQ:TER - Get Free Report) last posted its earnings results on Tuesday, July 29th. The company reported $0.57 EPS for the quarter, topping analysts' consensus estimates of $0.54 by $0.03. Teradyne had a return on equity of 18.16% and a net margin of 16.59%.The business had revenue of $651.80 million for the quarter, compared to analysts' expectations of $649.02 million. During the same quarter in the previous year, the firm earned $0.86 earnings per share. The business's revenue was down 10.7% compared to the same quarter last year. Teradyne has set its Q3 2025 guidance at 0.690-0.870 EPS. On average, equities research analysts forecast that Teradyne, Inc. will post 3.88 EPS for the current fiscal year.

Teradyne Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, September 29th. Investors of record on Friday, September 5th were issued a dividend of $0.12 per share. The ex-dividend date of this dividend was Friday, September 5th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.4%. Teradyne's dividend payout ratio (DPR) is currently 16.61%.

Insider Activity

In related news, CEO Gregory Stephen Smith sold 554 shares of the firm's stock in a transaction dated Monday, September 22nd. The stock was sold at an average price of $126.39, for a total transaction of $70,020.06. Following the transaction, the chief executive officer owned 95,885 shares of the company's stock, valued at $12,118,905.15. This trade represents a 0.57% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Insiders sold a total of 2,216 shares of company stock worth $251,028 over the last 90 days. Company insiders own 0.16% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the company. JPMorgan Chase & Co. restated a "neutral" rating and issued a $102.00 price target (up from $88.00) on shares of Teradyne in a research note on Thursday, July 17th. Morgan Stanley raised their price target on Teradyne from $100.00 to $136.00 and gave the company an "equal weight" rating in a research note on Tuesday. Weiss Ratings restated a "hold (c)" rating on shares of Teradyne in a research note on Wednesday, October 8th. UBS Group restated a "buy" rating and issued a $130.00 price target (up from $120.00) on shares of Teradyne in a research note on Thursday, July 31st. Finally, Cantor Fitzgerald set a $105.00 price target on Teradyne and gave the company an "overweight" rating in a research note on Tuesday, June 24th. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $124.93.

About Teradyne

Teradyne, Inc designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.